Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Diabetes news

Show

From To
Diabetes
Switching to Raltegravir or Dolutegravir Improves Leptin and Insulin in HIV

Switching to either raltegravir or dolutegravir from a ritonavir-boosted protease inhibitor during combination antiretroviral therapy (ART) has been associated with improved serum leptin levels and homeostasis model assessment of insulin resistance (HOMA) index scores in people with HIV infection, according to a study recently published in the Journal of Antimicrobial Chemotherapy.

Published
27 February 2019
From
Infectious Disease Advisor
Diabetes
As Waistlines Increase, Diabetes Sets In In Tanzania

Fast-changing lifestyle coupled with improving household economies have propelled the rate of obesity which culminates in diabetes at an alarming rate in Tanzania, with urban areas leading the tally. Medical experts say the metabolic disease is a looming health hazard in the country.

Published
16 January 2019
From
Health Policy Watch
Diabetes
Rising Incidence of Diabetes in Adults With HIV on Antiretroviral Therapy

The burden of diabetes and prediabetes is rapidly increasing in people living with HIV on antiretroviral therapy (ART), according to research published in Epidemiology.

Published
27 March 2018
From
Infectious Disease Advisor
Diabetes
Long-Term Treated HIV No Defense Against Diabetes Risk

It has long been thought that the heightened risk of diabetes among people living with HIV was mostly due to early-generation antiretroviral drugs that raised glucose levels. But a longitudinal Australian study published in the Feb. 20, 2018, issue of AIDS found that, even in the modern treatment era, HIV-positive men who have sex with men (MSM) developed diabetes at an extremely high rate.

Published
06 March 2018
From
The Body Pro
Diabetes
Older antiretroviral regimens raise diabetes risk in HIV-positive adults

HIV-positive adults who initiated older formulations of antiretroviral therapy are more likely to develop type 2 diabetes than patients who initiated therapy between 2010 and 2015, according to study findings reported in BMJ Open Diabetes Research.

Published
05 December 2017
From
Healio
Diabetes
Many adults with diabetes delay insulin therapy

Three in ten adults with type 2 diabetes who need to start taking insulin to lower their blood sugar don’t begin treatment when their doctors tell them to, a recent study suggests.

Published
02 October 2017
From
Reuters
Diabetes
Widely used diabetes test may not be suitable for Africans

People of African descent may mistakenly get the all-clear from a widely used type 2 diabetes test called HbA1c, according to an international study. The findings have important implications as they suggest that using this test as the sole means to diagnose diabetes would do harm, said University of the Witwatersrand endocrinologist Alisha Wade.

Published
14 September 2017
From
Medical Brief
Hepatitis C treatment
HCV eradication in HIV coinfected patients linked to reduced diabetes, chronic renal failure

Eradication of hepatitis C virus infection among patients coinfected with HIV was associated with reductions in diabetes and chronic renal failure in addition to reduced mortality, HIV progression and liver-related events, according to the results of a Spanish cohort study. These findings led investigators to conclude that HIV coinfected patients should receive HCV therapy regardless of their fibrosis stage.

Published
31 January 2017
From
Healio
Diabetes
People with HIV more likely to develop diabetes, study finds

A new study suggests the diabetes prevalence is much higher among HIV-positive individuals than the general population, even when obesity is not present.

Published
31 January 2017
From
HIV / AIDS News From Medical News Today
Diabetes
Diabetes drug may reduce heart attack risk in HIV patients

A diabetes drug may have benefits beyond lower blood sugar in patients with HIV. New research from Washington University School of Medicine in St. Louis suggests the drug may prevent cardiovascular problems because it works to reduce inflammation that is linked to heart disease and stroke in these patients. The drug both improved metabolism and reduced inflammation in HIV-positive adults on antiretroviral therapy.

Published
15 May 2015
From
Eurekalert Medicine & Health
← First123...4Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.